Hemlibra

Made by

• Chugai (Roche)

Active Ingredient

Emicizumab (genetical recombination)

Prospectus

Approval date

2018/3/23

Treats

• Hemophilia

Dosages

• HEMLIBRA for Subcutaneous Injection - 325524円／瓶

• HEMLIBRA for Subcutaneous Injection - 599582円／瓶

• HEMLIBRA for Subcutaneous Injection - 857075円／瓶

• HEMLIBRA for Subcutaneous Injection - 981775円／瓶

• HEMLIBRA for Subcutaneous Injection - 1344343円／瓶